At any given moment in time, more than 400 million individuals worldwide are battling depression. The antidepressant ...

Naoise Mac Giollabhui, PhD, of the Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in American Journal of ...

Doctors treating seriously ill patients in an emergency setting may want to give the sedative etomidate, rather than ketamine ...

Background Previous epidemiological studies demonstrated that premature atrial contractions (PACs) and premature ventricular ...

New FDA guidance signals a major shift for CAR-T development, calling for randomized trials with standard-of-care control groups and clear evidence of superiority over existing therapies, while ...

TXA is an inexpensive (approximately $3 per gram) and widely available antifibrinolytic medication with an established safety ...

Writing in JAMA, regulators said randomized controlled trials with a survival or time-to-event endpoint would be expected for approval of a new CAR T-cell therapy.

A low-protein diet, defined as 0.6 g/kg/day, is recommended for CKD patients, contrasting with the higher average intake in ...

A prominent anti-abortion group is pushing the Environmental Protection Agency to add mifepristone to a list of drinking ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

ORLANDO -- Patients with newly diagnosed chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) lived significantly longer without disease progression when treated with the Bruton's ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...